Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.
Ono H, Imoto I, Kozaki K, Tsuda H, Matsui T, Kurasawa Y, Muramatsu T, Sugihara K, Inazawa J.
Oncogene. 2012 Jan 30. doi: 10.1038/onc.2011.646. [Epub ahead of print]
Related citations
UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
Sabatino L, Fucci A, Pancione M, Carafa V, Nebbioso A, Pistore C, Babbio F, Votino C, Laudanna C, Ceccarelli M, Altucci L, Bonapace IM, Colantuoni V.
Oncogene. 2012 Jan 30. doi: 10.1038/onc.2012.3. [Epub ahead of print]
Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.
Rohlin A, Engwall Y, Fritzell K, Göransson K, Bergsten A, Einbeigi Z, Nilbert M, Karlsson P, Björk J, Nordling M.
Oncogene. 2011 Dec 15;30(50):4977-89. doi: 10.1038/onc.2011.201. Epub 2011 Jun 6.
The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4.
Lubbe SJ, Pittman AM, Olver B, Lloyd A, Vijayakrishnan J, Naranjo S, Dobbins S, Broderick P, Gómez-Skarmeta JL, Houlston RS.
Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.564. [Epub ahead of print]
Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel.
Sidler D, Brockmann A, Mueller J, Nachbur U, Corazza N, Renzulli P, Hemphill A, Brunner T.
Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.575. [Epub ahead of print]
Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death.
Wanka C, Brucker DP, Bähr O, Ronellenfitsch M, Weller M, Steinbach JP, Rieger J.
Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.530. [Epub ahead of print]
The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients.
Neeb A, Wallbaum S, Novac N, Dukovic-Schulze S, Scholl I, Schreiber C, Schlag P, Moll J, Stein U, Sleeman JP.
Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.535. [Epub ahead of print]
Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
Kawada M, Seno H, Kanda K, Nakanishi Y, Akitake R, Komekado H, Kawada K, Sakai Y, Mizoguchi E, Chiba T.
Oncogene. 2011 Nov 7. doi: 10.1038/onc.2011.498. [Epub ahead of print]
p53 promotes cellular survival in a context-dependent manner by directly inducing the expression of haeme-oxygenase-1.
Nam SY, Sabapathy K.
Oncogene. 2011 Nov 3;30(44):4476-86. doi: 10.1038/onc.2011.150. Epub 2011 May 9.
A novel tumor-derived SGOL1 variant causes abnormal mitosis and unstable chromatid cohesion.
Kahyo T, Iwaizumi M, Shinmura K, Matsuura S, Nakamura T, Watanabe Y, Yamada H, Sugimura H.
Oncogene. 2011 Nov 3;30(44):4453-63. doi: 10.1038/onc.2011.152. Epub 2011 May 2.
Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Orntoft TF, Andersen CL.
Oncogene. 2012 May 31;31(22):2750-60. doi: 10.1038/onc.2011.453. Epub 2011 Oct 3.
Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells.
Taketani K, Kawauchi J, Tanaka-Okamoto M, Ishizaki H, Tanaka Y, Sakai T, Miyoshi J, Maehara Y, Kitajima S.
Oncogene. 2012 Apr 26;31(17):2210-21. doi: 10.1038/onc.2011.397. Epub 2011 Sep 19.
Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation.
Takai A, Marusawa H, Minaki Y, Watanabe T, Nakase H, Kinoshita K, Tsujimoto G, Chiba T.
Oncogene. 2012 Mar 29;31(13):1733-42. doi: 10.1038/onc.2011.352. Epub 2011 Aug 15.
A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells.
Zhu G, Wang Y, Huang B, Liang J, Ding Y, Xu A, Wu W.
Oncogene. 2012 Feb 23;31(8):1001-12. doi: 10.1038/onc.2011.294. Epub 2011 Aug 8.
Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms.
Khromova N, Kopnin P, Rybko V, Kopnin BP.
Oncogene. 2012 Mar 15;31(11):1389-97. doi: 10.1038/onc.2011.330. Epub 2011 Aug 1.
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.
Oh JH, Cho MC, Kim JH, Lee SY, Kim HJ, Park ES, Ban JO, Kang JW, Lee DH, Shim JH, Han SB, Moon DC, Park YH, Yu DY, Kim JM, Kim SH, Yoon DY, Hong JT.
Oncogene. 2011 Jul 28;30(30):3345-59. doi: 10.1038/onc.2011.52. Epub 2011 Mar 21.
Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells.
Wang D, Ning W, Xie D, Guo L, DuBois RN.
Oncogene. 2012 Feb 23;31(8):1013-23. doi: 10.1038/onc.2011.299. Epub 2011 Jul 18.
Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells.
Zaric J, Joseph JM, Tercier S, Sengstag T, Ponsonnet L, Delorenzi M, Rüegg C.
Oncogene. 2012 Jan 5;31(1):48-59. doi: 10.1038/onc.2011.218. Epub 2011 Jun 13.
p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
Testoni B, Schinzari V, Guerrieri F, Gerbal-Chaloin S, Blandino G, Levrero M.
Oncogene. 2011 Jun 9;30(23):2670-8. doi: 10.1038/onc.2010.635. Epub 2011 Mar 14.
HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
Li Y, Bavarva JH, Wang Z, Guo J, Qian C, Thibodeau SN, Golemis EA, Liu W.
Oncogene. 2011 Jun 9;30(23):2633-43. doi: 10.1038/onc.2010.632. Epub 2011 Feb 14.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on